Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Our approach is built on creating a genuine partnership with you
Appropriate dosing and monitoring
0.2 mL delivers the 3 mg target
:max_bytes(150000):strip_icc()/VWH-GettyImages-2276706586.jpg-4e49ad1f948143ed99767b89bf0289d7.jpg)
Adjacent human safety: Increlex (mecasermin) FDA label 71 pediatric patients with severe primary IGFD treated for a mean of 3.9 years
Timing considerations KLOW can be administered at any time of day, but most protocols recommend morning dosing
Patients with pernicious anemia have an irreversible cause of deficiency, so its important to ensure other factors do not contribute to further deficiency progression
US$ 26.60
US$ 25.31
US$ 29.84
US$ 23.13
